Insider Insights
01.11.2022
Germany: Significant interest has been aroused by ...

From 2016, the Innovation Fund has served as an instrument of central health policy to promote new f...

Read more
Insider Insights
27.10.2022
Financial Stabilisation Act is passed, sparks crit...

This law is projected to have a large impact on the pharmaceutical industry and pharmacies nationwid...

Read more
Insider Insights
27.10.2022
France: Biologists take strike action against PLFS...

The PLFSS requires laboratories to lower the prices of their routine examinations leading to savings...

Read more
Insider Insights
18.10.2022
UK Agencies join with International HTA Partners f...

A cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can...

Read more
Insider Insights
18.10.2022
US Pharma Amylyx in hot water over exorbitant pric...

Amylyx has set the annual price of the ALS drug to $158,000, whereas ICER have suggested the drug sh...

Read more
Insider Insights
12.10.2022
France: Implications for Pharma of the proposed So...

Leem report the changes set out by the Government will heighten the difficulties already being faced...

Read more
Insider Insights
06.10.2022
Germany: Pros and cons of register-based randomise...

Study designs that combine explanatory and pragmatic aspects have recently been weighted up by autho...

Read more
Insider Insights
06.10.2022
DEKRA becomes the first new body for certifying me...

The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed DEKRA as the first new ...

Read more
Insider Insights
06.10.2022
France: An update on the transitional reimbursemen...

The aim of the transitional reimbursement mechanism (PECT) launched in February 2021, was to allow r...

Read more
Insider Insights
05.10.2022
Germany: Experts criticise the GKV’s financial s...

On 28th September there was a two-hour public hearing on the GKV Financial Stabilisation Act. There ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.